— Know what they know.
Not Investment Advice

298380.KQ

ABL Bio Inc.
1W: -5.3% 1M: -5.3% 3M: +84.5% YTD: -3.2% 1Y: +384.9% 3Y: +704.9%
₩179,800.00 ($119.50)
-100.00 (-0.06%)
 
KOE · Healthcare · Medical - Pharmaceuticals · ₩9.92T
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₩9.92T ($6.6B)
52W Range31300-257500
Volume350,205
Avg Volume1,092,510
Beta0.47
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOSang Hoon Lee
Employees102
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2018-12-19
Websiteablbio.com
16 Daewangpangyo-Ro 712 Beon-Gil
Seongnam 13488
KR
82 31 8018 9800
About ABL Bio Inc.

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms